Search Result "p21Ras/MAPK pathway"
“Something is Wrong in the Ras Kingdom” - Evidence for the Involvement of p21Ras/MAP Kinase in Autoimmune Diseases
Journal: Current Rheumatology Reviews
Volume: 7 Issue: 4 Year: 2011 Page: 301-305
Author(s): Rapoport M.J., Bloch O., Amit-Vazina M.
The PKB/AKT Pathway in Cancer
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 1 Year: 2010 Page: 34-44
Author(s): Amancio Carnero
Anti-Cancer Therapy: Targeting the Mevalonate Pathway
Journal: Current Cancer Drug Targets
Volume: 6 Issue: 1 Year: 2006 Page: 15-37
Author(s): Kelly M. Swanson, Raymond J. Hohl
Involvement of Targeting and Scaffolding Proteins in the Regulation of the EGFR/Ras/MAPK Pathway in Oncogenesis
Journal: Current Signal Transduction Therapy
Volume: 1 Issue: 2 Year: 2006 Page: 147-167
Author(s): Thomas Grewal, Francesc Tebar, Albert Pol, Carlos Enrich
Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases
Journal: Current Signal Transduction Therapy
Volume: 4 Issue: 3 Year: 2009 Page: 201-221
Author(s): Charles Jay Malemud, Eric Pearlman
Targeting the L-Arginine-Nitric Oxide Pathway for Cancer Treatment
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 4 Year: 2010 Page: 392-410
Author(s): Qingyong Ma, Zheng Wang, Min Zhang, Hengtong Hu, Junhui Li, Dong Zhang, Kun Guo, Huanchen Sha
Endothelin-1-Induced Signaling Pathways in Vascular Smooth Muscle Cells
Journal: Current Vascular Pharmacology
Volume: 5 Issue: 1 Year: 2007 Page: 45-52
Author(s): Ali Bouallegue, Grace Bou Daou, Ashok K. Srivastava
New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 3 Year: 2006 Page: 327-340
Author(s): Niels W.C.J. van de Donk, Andries C. Bloem, Ellen v. d. Spek, Henk M. Lokhorst
The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 3 Year: 2008 Page: 187-198
Author(s): Amancio Carnero, Carmen Blanco-Aparicio, Oliver Renner, Wolfgang Link, Juan F.M. Leal
Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 9 Year: 2014 Page: 1615-1626
Author(s): Julio C. Tobon-Velasco,Elvis Cuevas,Mónica A. Torres-Ramos